Clinical Medicine Frontiers is an international, peer-reviewed open access journal dedicated to advancing research the field of clinical medicine. The journal provides a rapid publication process to ensure wide dissemination of high-quality articles to scientists, professionals, and interested individuals worldwide. Our goal is to serve as an efficient, reliable, and trusted platform for scholars and readers, publishing cutting-edge research in the field.
Abstract: Background: This study aims to analyze the factors influencing the survival and prognosis of patients with locally advanced cervical cancer (LACC) after neoadjuvant chemotherapy (NACT), so as to provide theoretical guidance for clinical work. Methods: A total of 263 patients diagnosed with stage IB3, IIA2, IIB and IIIC1r cervical cancer according to FIGO 2018 criteria were enrolled in this retrospective study. They were admitted to First Affiliated Hospital of Chongqing Medical University from January 2018 to December 2021. After receiving 1-4 cycles of "platinum + paclitaxel" chemotherapy and effective NACT, the patients accepted surgery including radical hysterectomy and pelvic lymph node dissection. All patients with one of high-risk factors or two of medium-risk factors are exposed to additional radiation according to post-operative pathological risk factors. Patients were divided into two parts based on whether or not radiotherapy was supplemented after surgery. The baseline characteristics, treatment plan, pathological characteristics and survival prognosis of the two groups were compared in this study. The main endpoint of the study was recurrence or death within 2 years. The 2-year progression-free survival (PFS) rate was compared between the two groups in order to analyze the risk factors affecting prognosis. Results: In this study, 59 patients without supplemental radiotherapy and 204 patients with supplemental radiotherapy were included. The 2-year PFS rate was 98.10% and 98.90% respectively (p=0.606) in the group with and without supplementary radiotherapy. Univariate analysis showed that parastatal infiltration and lympho-vascular space infiltration were risk factors for 2-year PFS, while multivariate analysis showed that only lympho-vascular space infiltration was independent risk factor for PFS. Conclusion: In conclusion, NACT can also reduce the occurrence of radiotherapy in addition to obtaining the opportunity of surgery, so as to improve the quality of life of patients without affecting survival. Meanwhile, LVSI is an independent risk factor for progression-free survival in patients with locally advanced cervical cancer who receive NACT. For such patients, complementary treatment after surgery is more helpful to ensure prognosis.Abstract: Background: This study aims to analyze the factors influencing the survival and prognosis of patients with locally advanced cervical cancer (LACC) after neoadjuvant chemotherapy (NACT), so as to provide theoretical guidance for clinical work. Methods: A total of 263 patients diagnosed with stage IB3, IIA2, IIB and IIIC1r cervical cancer according t...Learn More
Abstract: Objective: Proliferating trichilemmal tumor is uncommon tumors that develop from the hair follicle's outer root sheath. They frequently correspond to the transition of a simple trichilemmal cyst, and they typically occur on the scalp of elderly women. However, multiple proliferating trichilemmal tumor are more rare and difficult to diagnose. Therefore, the diagnosis and treatment of this disease were discussed based on the relevant literature and the clinical data of multiple proliferating trichilemmal tumor in our hospital. Methods: The clinical data of a 74 year old female patient with multiple proliferating trichilemmal tumor and positive family history admitted to department of dermatology were retrospectively analyzed, combined with relevant literature review and discussion. Results: After surgical radical treatment, it is suggested to be multiple proliferating trichilemmal tumor based on the pathological result and immunohistochemical results. Conclusion: Proliferating trichilemmal tumors a rare but morphologically distinctive tumor. The diagnosis is mainly based on pathological results. Based on the histopathologic findings of tumor, this case was diagnosed as proliferating trichilemmal tumor. Surgery is the first choice for treatment. The patient’s condition was successfully treated with total excision. Regular postoperative review is required. Proliferating trichilemmal tumor need to be diagnosed and treated using a multidisciplinary strategy. Close clinical follow-up is the most efficient method of early metastasis and recurrence detection.Abstract: Objective: Proliferating trichilemmal tumor is uncommon tumors that develop from the hair follicle's outer root sheath. They frequently correspond to the transition of a simple trichilemmal cyst, and they typically occur on the scalp of elderly women. However, multiple proliferating trichilemmal tumor are more rare and difficult to diagnose. Theref...Learn More
